Clinical Trials

43 enrolled 27 charts

Lymphoid

Lymphoma, Non-Hodgkin

NCT02036502 2021-04-08

MK-3475-023

77 enrolled 23 charts

Multiple Myeloma

NCT03050450 2021-04-05

Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors

8 enrolled 10 charts

CNS

Central Nervous System Neoplasms

NCT01742793 2020-03-04

RID

12 enrolled

LymphoidPlasma cell

Hodgkin Disease, Multiple Myeloma, Lymphoma, T-Cell

NCT02370888 2020-01-27

UF-BMT-MRD-101

MyeloidOther hematologic neoplasm

11 enrolled 3 charts

Leukemia, Myeloid, Myelodysplastic Syndromes

NCT01729104 2019-10-22

Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

18 enrolled

Lymphoid

Lymphoma, Recurrence, Lymphoma, Mantle-Cell

NCT00687674 2019-08-20

Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

13 enrolled 7 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT03558750 2019-04-25

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

6 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00671801 2018-11-13

Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I

24 enrolled

CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT01904643 2018-10-29

Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Other hematologic neoplasm

17 enrolled

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT02030483 2018-08-22

PD + RD

9 enrolled

Multiple Myeloma

NCT02018523 2018-01-18

Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer

7 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02200848 2018-01-12

Phase I Study of Lenalidomide, Rituximab and Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

5 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02255162 2017-08-18

Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML

Other hematologic neoplasm

8 enrolled

Leukemia, Myeloid, Acute

NCT01034592 2017-08-02

Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia

Classical hematologyMyeloidOther hematologic neoplasm

2 enrolled 9 charts

Anemia, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01750762 2017-04-18

Lenalidomide After Allo Transplant

1 enrolled

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT01954784 2017-02-17

Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma

8 enrolled

Multiple Myeloma

NCT00933426 2016-10-26

Lenalidomide and Paclitaxel in Prostate Cancer

17 enrolled

Genitourinary

Prostatic Neoplasms

NCT01985477 2016-09-14

Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma

2 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00543114 2016-05-27

Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL

9 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01604031 2016-02-08

TAIL

2 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01045928 2015-11-26

Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma

5 enrolled

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01348503 2015-08-31

Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma

5 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT01005979 2014-08-13

A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)

6 enrolled

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01202890 2014-01-08

Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer

1 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00923234 2013-12-18

AZALE

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01200004 2013-08-02

Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide

1 enrolled

Advanced Cancers

NCT01126450 2012-03-20

Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer

3 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT00839059 2011-07-29

Lenalidomide In Patients With Acute Myeloid Leukemia

Other hematologic neoplasm

14 enrolled

Leukemia, Myeloid, Acute

NCT01116154 2010-12-09

Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

DermatologicLymphoidOther hematologic neoplasm

30 enrolled

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

NCT00179699 2005-11-07

Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer